Biotech Values

[biotech jim]

Thanks for the comments, W.

In my investing consortium, we discussed HeFH population size after your post the other day. Esp regarding the Repatha in Canada difficulty in getting a script. Thanks for that.

The results from the CC this am said in Jan for the HeFH data set release. But I have to caution, that I need to listen to the CC again to provide some more detail. I was busy multi-tasking and smiling.

I can say that Drs. Friedman and Taub are quite bullish on this trial, but that is their job.